Labetalol: Difference between revisions

(Created page with "== Adult Dosing == *Bolus dosing **20mg IV followed by 40-80mg q10min up to total of 300mg *Infusion dosing **0.5-2mg/min == Indications == *HTN in setting of myocardial ischemi...")
 
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(19 intermediate revisions by 8 users not shown)
Line 1: Line 1:
== Adult Dosing ==
==General==
*Type: [[Beta blockers]]
*Dosage Forms:
*Common Trade Names:
 
==Adult Dosing==
*Bolus dosing
*Bolus dosing
**20mg IV followed by 40-80mg q10min up to total of 300mg
**20mg IV followed by 40-80mg q10min up to total of 300mg
Line 5: Line 10:
**0.5-2mg/min
**0.5-2mg/min


== Indications ==
===[[Intracranial hemorrhage]]===
*HTN in setting of myocardial ischemia
*Start with labetalol 20mg over 1-2 minutes
*HTN in setting of neurologic injury
**Then, 20mg q3-5 mins until target blood pressure is achieved
*HTN in setting of preeclampsia/eclampsia
**Then, start an infusion of 1-8mg/min


== Mechanism of Action ==
==Pediatric Dosing==
*Class II - Nonselective beta blocker
*Alpha1 blocker


== Adverse Drug Rxns ==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
*Lactation: Compatible with breastfeeding
*Renal Dosing
**Adult
*** No renal dosing adjustments necessary. Drug not removed with hemodialysis
**Pediatric
*** No renal dosing adjustments necessary. Drug not removed with hemodialysis
*Hepatic Dosing
**Adult
*** May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.
**Pediatric
*** May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.
 
==Indications==
*hypertension in setting of myocardial ischemia
*hypertension in setting of neurologic injury
*hypertension in setting of preeclampsia/eclampsia
 
==Contraindications==
*Allergy to class/drug
 
==Adverse Reactions==
*Orthostatic hypotension
*Orthostatic hypotension


== Kinetics ==
==Pharmacology==
*Half-life: 5-8hrs
*Metabolism: Hepatic via conjugation
*Excretion: Renal 55-60%
*Mechanism of Action:
**Class II - Nonselective β-blocker
**α<sub>1</sub>-blocker
*Onset of action = 2-5min (IV)
*Onset of action = 2-5min (IV)
*Duration of action = 2-4hr (IV)
*Duration of action = 2-4hr (IV)
==Indications by Condition==
''The following table is automatically generated from disease/condition pages across WikEM.''
{{#ask:[[Has DrugName::Labetalol]]
|?Has Indication=Indication
|?Has Dose=Dose
|?Has Context=Context
|?Has Route=Route
|?Has Population=Population
|format=table
|headers=plain
|mainlabel=-
|sort=Has Indication
|limit=50
}}


==See Also==
==See Also==
[[Antiarrhythmics]
*[[Beta-blockers]]
*[[Beta-blocker toxicity]]
*[[Antiarrhythmics]]
*[[Antihypertensive medications]]
 
==References==
<references/>
 
[[Category:Pharmacology]]
[[Category:Cardiology]]


[[Cateogry:Drugs]]
Labetalol: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.

Latest revision as of 21:55, 20 March 2026

General

Adult Dosing

  • Bolus dosing
    • 20mg IV followed by 40-80mg q10min up to total of 300mg
  • Infusion dosing
    • 0.5-2mg/min

Intracranial hemorrhage

  • Start with labetalol 20mg over 1-2 minutes
    • Then, 20mg q3-5 mins until target blood pressure is achieved
    • Then, start an infusion of 1-8mg/min

Pediatric Dosing

Special Populations

  • Pregnancy Rating: C
  • Lactation: Compatible with breastfeeding
  • Renal Dosing
    • Adult
      • No renal dosing adjustments necessary. Drug not removed with hemodialysis
    • Pediatric
      • No renal dosing adjustments necessary. Drug not removed with hemodialysis
  • Hepatic Dosing
    • Adult
      • May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.
    • Pediatric
      • May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.

Indications

  • hypertension in setting of myocardial ischemia
  • hypertension in setting of neurologic injury
  • hypertension in setting of preeclampsia/eclampsia

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Orthostatic hypotension

Pharmacology

  • Half-life: 5-8hrs
  • Metabolism: Hepatic via conjugation
  • Excretion: Renal 55-60%
  • Mechanism of Action:
    • Class II - Nonselective β-blocker
    • α1-blocker
  • Onset of action = 2-5min (IV)
  • Duration of action = 2-4hr (IV)


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Hypertensive emergency20 mg IV bolus, double q10 min (max 300 mg) or 0.5-2 mg/min drip1st line antihypertensiveIVAdult
Intracranial hemorrhage (main)20 mg IV bolus, repeat q3-5 min; then 1-8 mg/min dripBP control in ICHIVAdult
Nontraumatic thoracic aortic dissection20mg bolus, then 40-80mg q10min (max 300mg) or 1-2mg/min dripHeart rate and blood pressure controlIVAdult
Stroke (main)10-20 mg IV push, may repeat x1BP control in acute strokeIVAdult
Traumatic intracerebral hemorrhage20 mg IV bolus, repeat q3-5 min; then 1-8 mg/min dripBP control in ICHIVAdult

See Also

References


Labetalol: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.